Paper33995652
A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.
Alcaraz LB and 19 others. Theranostics, 2021. Cited by 42 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment. Papers, record 33995652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33995652
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cathepsin D | Major topic |
| Extracellular Matrix | Major topic |
| Neoplasm Proteins | Major topic |
| Osteonectin | Major topic |
| Peptide Fragments | Major topic |
| Triple Negative Breast Neoplasms | Major topic |
| Tumor Microenvironment | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Binding Sites | |
| Cell Adhesion | |
| Female | |
| Fibroblasts | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Mammary Neoplasms, Experimental | |
| Mice | |
| Mice, Knockout | |
| Mice, Transgenic | |
| Molecular Weight | |
| Neoplasm Invasiveness | |
| Protein Domains | |
| Proteolysis | |
| Substrate Specificity | |
| Transendothelial and Transepithelial Migration |
Source PubMed
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16,173,048 | Roles of osteonectin in the migration of breast cancer cells into bone. | J Cell Biochem | 2006 | https://conductscience.org/library/papers/16173048 | PubMed |
| 2 | 11,102,747 | SPARC, a matricellular protein: at the crossroads of cell-matrix. | Matrix Biol | 2000 | https://conductscience.org/library/papers/11102747 | PubMed |
| 3 | 2,269,665 | Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape. | J Cell Biol | 1990 | https://conductscience.org/library/papers/2269665 | PubMed |
| 4 | 32,429,078 | Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32429078 | PubMed |
| 5 | 20,020,197 | An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. | Breast Cancer Res Treat | 2010 | https://conductscience.org/library/papers/20020197 | PubMed |
| 6 | 25,064,829 | Revisiting the matricellular concept. | Matrix Biol | 2014 | https://conductscience.org/library/papers/25064829 | PubMed |
| 7 | 3,948,791 | Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. | Endocrinology | 1986 | https://conductscience.org/library/papers/3948791 | PubMed |
| 8 | 32,193,287 | The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment. | Cancer Res | 2020 | https://conductscience.org/library/papers/32193287 | PubMed |
| 9 | 12,370,830 | Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells. | Oncogene | 2002 | https://conductscience.org/library/papers/12370830 | PubMed |
| 10 | 21,959,240 | Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates. | Nat Protoc | 2011 | https://conductscience.org/library/papers/21959240 | PubMed |
| 11 | 10,708,860 | The two sides of enzyme-substrate specificity: lessons from the aspartic proteinases. | Biochim Biophys Acta | 2000 | https://conductscience.org/library/papers/10708860 | PubMed |
| 12 | 24,675,529 | Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. | Carcinogenesis | 2014 | https://conductscience.org/library/papers/24675529 | PubMed |
| 13 | 12,500,936 | Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition. | Breast Cancer Res Treat | 2002 | https://conductscience.org/library/papers/12500936 | PubMed |
| 14 | 24,490,606 | Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer. | Future Oncol | 2014 | https://conductscience.org/library/papers/24490606 | PubMed |
| 15 | 22,718,352 | Autocrine control of glioma cells adhesion and migration through IRE1α-mediated cleavage of SPARC mRNA. | J Cell Sci | 2012 | https://conductscience.org/library/papers/22718352 | PubMed |
| 16 | 19,700,761 | Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. | Am J Pathol | 2009 | https://conductscience.org/library/papers/19700761 | PubMed |
| 17 | 10,801,822 | Calcium affinity, cooperativity, and domain interactions of extracellular EF-hands present in BM-40. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10801822 | PubMed |
| 18 | 8,245,016 | Specific interaction of SPARC with endothelial cells is mediated through a carboxyl-terminal sequence containing a calcium-binding EF hand. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8245016 | PubMed |
| 19 | 27,681,434 | Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity. | Cell Rep | 2016 | https://conductscience.org/library/papers/27681434 | PubMed |
| 20 | 20,818,432 | Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. | Oncogene | 2011 | https://conductscience.org/library/papers/20818432 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,656,947 | Exercise-induced myokines and the muscle-tumor axis in obesity-driven gynecological cancers: a narrative review. | Front Oncol | 2026 | https://conductscience.org/library/papers/42656947 | PubMed |
| 41,983,081 | The role of exercise-induced myokines in cancer-associated inflammation and immune regulation: mechanisms and prospects. | Front Sports Act Living | 2026 | https://conductscience.org/library/papers/41983081 | PubMed |
| 41,739,603 | A Degradomic Landscape of Proteolytic Remodeling in Melanoma Lung Metastasis. | J Proteome Res | 2026 | https://conductscience.org/library/papers/41739603 | PubMed |
| 41,673,191 | The contribution of phenolic endocrine-disrupting chemicals to breast cancer risk: A comprehensive bioinformatics analysis. | Sci Rep | 2026 | https://conductscience.org/library/papers/41673191 | PubMed |
| 41,535,351 | Identification and validation of a refined CAF-Associated diagnostic signature in breast cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/41535351 | PubMed |
| 41,399,382 | Integration of Single-cell and Bulk Transcriptome Analyses Unravels a Macrophage-based Gene Signature for Prognostication and Treatment in Triple-negative Breast Cancer. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/41399382 | PubMed |
| 41,296,505 | Design and Preclinical Evaluation of First 68Ga-Labeled Cathepsin D-Targeted Radiotracers. | J Med Chem | 2025 | https://conductscience.org/library/papers/41296505 | PubMed |
| 41,256,421 | Collagen-Based Tumor Spheroid Model for Investigating Tumor-Macrophage Interactions through Extracellular Matrix Remodeling. | bioRxiv | 2025 | https://conductscience.org/library/papers/41256421 | PubMed |
| 41,185,072 | SPARC-modified mesenchymal stem cells promote recovery of β-cells and insulin secretion by calcium ion homeostasis. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41185072 | PubMed |
| 40,964,713 | Identifying protease-activated targets and exploring therapeutic applications. | Expert Opin Ther Targets | 2025 | https://conductscience.org/library/papers/40964713 | PubMed |
| 40,861,820 | Paxillin promotes the invasion and migration of polyploid giant cancer cells with daughter cells after arsenic trioxide treatment by regulating the expression of cathepsin B/D. | J Cancer | 2025 | https://conductscience.org/library/papers/40861820 | PubMed |
| 40,784,956 | CAFs exosomal circFOXO1 promotes TNBC autophagy and radioresistance via miR-27a-3p/BNIP3 axis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40784956 | PubMed |
| 40,228,591 | Cathepsins: Emerging targets in the tumor ecosystem to overcome cancers. | Semin Cancer Biol | 2025 | https://conductscience.org/library/papers/40228591 | PubMed |
| 39,813,225 | N-terminomics profiling of host proteins targeted by excretory-secretory proteases of the nematode Angiostrongylus vasorum identifies points of interaction with canine coagulation and complement cascade. | PLoS One | 2025 | https://conductscience.org/library/papers/39813225 | PubMed |
| 39,800,383 | Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/39800383 | PubMed |
| 39,019,115 | Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis. | Mol Metab | 2024 | https://conductscience.org/library/papers/39019115 | PubMed |
| 38,290,768 | A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/38290768 | PubMed |
| 38,007,443 | Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/38007443 | PubMed |
| 37,577,749 | SPARC: a potential target for functional nanomaterials and drugs. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37577749 | PubMed |
| 36,648,960 | Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice. | Proteomes | 2023 | https://conductscience.org/library/papers/36648960 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33995652
GET https://conductscience.org/api/papers/v1/33995652/references?page=2